Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Rose Mulwana"'
Autor:
Gift Ahimbisibwe, Marjorie Nakibuule, Marvin Martin Ssejoba, David Oyamo, Rose Mulwana, Josephine Nabulime, Febronius Babirye, Musana Abdusalaamu Kizito, Hervé Monka Lekuya, Akello Suzan Adakun, Daisy Nalumansi, Stella Muryasingura, Robert Lukande, Andrew Kyazze, Joseph Baruch Baluku, Irene Andia Biraro, Stephen Cose
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionIf we are to break new ground in difficult-to-treat or difficult-to-vaccinate diseases (such as HIV, malaria, or tuberculosis), we must have a better understanding of the immune system at the site of infection in humans. For tuberculosis
Externí odkaz:
https://doaj.org/article/73950710c66b438a9701d1dc3fe8ebd4
Autor:
Joseph Baruch Baluku, Godwin Anguzu, Sylvia Nassozi, Febronius Babirye, Sharon Namiiro, Robert Buyungo, Mike Sempiira, Amir Wasswa, Rose Mulwana, Samuel Ntambi, William Worodria, Irene Andia-Biraro
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Abstract Individuals found at bars in slums have several risk factors for HIV and tuberculosis (TB). To determine the prevalence of HIV and TB among individuals found at bars in slums of Kampala, Uganda, we enrolled adults found at bars that provided
Externí odkaz:
https://doaj.org/article/4d07ba55fdf049549e6c5c67fe6982ff
Autor:
Joseph Baruch Baluku, Bridget Nakazibwe, Joshua Naloka, Martin Nabwana, Sarah Mwanja, Rose Mulwana, Mike Sempiira, Sylvia Nassozi, Febronius Babirye, Carol Namugenyi, Samuel Ntambi, Sharon Namiiro, Felix Bongomin, Richard Katuramu, Irene Andia-Biraro, William Worodria
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 23, Iss , Pp 100221- (2021)
Background: Comorbid conditions and adverse drug events are associated with poor treatment outcomes among patients with drug resistant tuberculosis (DR – TB). This study aimed at determining the treatment outcomes of DR – TB patients with poor pr
Externí odkaz:
https://doaj.org/article/2a4b2f3e004f4b05b5fee67c594609cb
Autor:
Joseph Baruch Baluku, Joseph Musaazi, Rose Mulwana, Derrick Bengo, Christine Sekaggya Wiltshire, Irene Andia-Biraro
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 21, Iss , Pp 100205- (2020)
Background: There is need for simple, cost effective and widely available point of care tests for low level health facilities in developing countries to screen for drug resistant tuberculosis (TB) after bacteriological confirmation of TB by smear mic
Externí odkaz:
https://doaj.org/article/c7f5a8091a5f47d8a0a716b89830b97a
Autor:
Gift Ahimbisibwe, Marjorie Nakibuule, Marvin Martin Ssejoba, David Oyamo, Rose Mulwana, Josephine Nabulime, Febronius Babirye, Abdusalaamu Kizito, Herve Lekuya, Akello Suzan Adakun, Robert Lukande, Andrew Kyazze, Irene Andia Biraro, Stephen Cose
If we are to break new grounds in TB research, we need to have a complete understanding of what is occurring at the site of infection in humans. Postmortem studies give us an opportunity to compare TB-involved and -uninvolved tissues, in both disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00822a9b7dcd171e865e56ccc2c19ba0
https://doi.org/10.1101/2023.03.14.532701
https://doi.org/10.1101/2023.03.14.532701
Autor:
Rose Mulwana, Joseph Baruch Baluku, Joseph Musaazi, Winceslaus Katagira, Felix Bongomin, Araali Robert Mugabo
Publikováno v:
Research and Reports in Tropical Medicine. 11:45-51
Purpose CD4+ T-lymphocytopenia is a risk for tuberculosis (TB) infection, reactivation and severe disease. We sought to determine the prevalence and predictors of CD4 T-lymphocytopenia among HIV-negative patients with bacteriologically confirmed TB i
Autor:
Bridget Nakazibwe, Sarah Mwanja, Carol Namugenyi, Febronius Babirye, Joshua Naloka, William Worodria, Mike Sempiira, Joseph Baruch Baluku, Rose Mulwana, Samuel Ntambi, Sylvia Nassozi, Sharon Namiiro, Richard Katuramu, Felix Bongomin, Irene Andia-Biraro, Martin Nabwana
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 23, Iss, Pp 100221-(2021)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 23, Iss, Pp 100221-(2021)
Background: Comorbid conditions and adverse drug events are associated with poor treatment outcomes among patients with drug resistant tuberculosis (DR – TB). This study aimed at determining the treatment outcomes of DR – TB patients with poor pr
Autor:
Irene Andia-Biraro, Derrick Bengo, Rose Mulwana, Christine Sekaggya Wiltshire, Joseph Baruch Baluku, Joseph Musaazi
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 21, Iss, Pp 100205-(2020)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Background: There is need for simple, cost effective and widely available point of care tests for low level health facilities in developing countries to screen for drug resistant tuberculosis (TB) after bacteriological confirmation of TB by smear mic
Autor:
Irene Andia-Biraro, William Worodria, Robert Buyungo, Joseph Baruch Baluku, Amir Wasswa, Godwin Anguzu, Samuel Ntambi, Sylvia Nassozi, Rose Mulwana, Sharon Namiiro, Febronius Babirye, Mike Sempiira
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Individuals found at bars in slums have several risk factors for HIV and tuberculosis (TB). To determine the prevalence of HIV and TB among individuals found at bars in slums of Kampala, Uganda, we enrolled adults found at bars that provided written
Autor:
Joseph Baruch Baluku, Rose Mulwana, Pallen Mugabe, Sylvia Nassozi, William Worodria, Richard Katuramu
Publikováno v:
BioMed Research International, Vol 2020 (2020)
BioMed Research International
BioMed Research International
Background. Rifampicin resistance (RR) is associated with mortality among tuberculosis (TB) patients coinfected with HIV. We compared the prevalence of RR among TB patients with and without HIV coinfection at the National Tuberculosis Treatment Cente